West pushing Russia beyond ‘red line’ – Putin
RT | December 16, 2024
The West’s support for Ukraine is pushing Russia to the point where it cannot help but retaliate, President Vladimir Putin has said, while warning the US against deploying medium-range missiles.
Speaking at a meeting of top Russian Defense Ministry officials on Monday, Putin accused the US of seeking “to weaken our country and inflict a strategic defeat” on Moscow by continuing “to pump a de facto illegitimate ruling regime in Kiev with weapons and money, sending mercenaries and military advisers, thereby encouraging further escalation of the conflict.”
Washington is instilling fear in Americans by resorting to “simple tactics,” Putin stated. “They push us to the red line… we begin to respond, and then they frighten their population,” he added, suggesting that the US used the same approach during its rivalry with the Soviet Union.
The Russian president also slammed the West for what he described as attempts to impose its own rules on the rest of the world while waging “hybrid wars” against anyone who resists, including Russia.
In this vein, NATO is boosting its defense spending and forming “strike groups” near Russia’s borders, he added. “The number of American service members in Europe has already exceeded 100,000 troops,” he noted.
NATO is ramping up its presence not only in Europe but also in regions that have never seen this type of military footprint, particularly the Asia-Pacific, Putin said, voicing particular concerns over US plans to deploy missile systems with a range of up to 5,500km.
Putin was referring to a type of weapon previously banned by the Cold War-era Intermediate-Range Nuclear Forces (INF) Treaty. The US unilaterally pulled out of the treaty in 2018, citing Russian non-compliance – an allegation Moscow has denied.
The Russian president stressed that despite Washington’s withdrawal from the INF Treaty, Moscow made a unilateral and voluntary commitment not to deploy medium- and short-range missiles unless the US deploys such weapons anywhere in the world.
However, “if the United States begins to deploy such systems, then all our voluntary restrictions will be lifted,” Putin warned.
FDA Advisers Bullish on RSV Shots for Kids, Even as Safety Signals Shut Down Moderna Trials
By Brenda Baletti, Ph.D. | The Defender | December 13, 2024
Advisers to the U.S. Food and Drug Administration (FDA) met Thursday to discuss the future of pediatric respiratory syncytial virus (RSV) vaccines after Moderna was forced to abruptly halt clinical trials for its mRNA RSV vaccine in children ages 5-23 months.
Clinical trial data released earlier this week in an FDA briefing document showed that rather than preventing RSV disease in small children, Moderna’s vaccine likely caused higher rates of severe RSV illness in its Phase 1 clinical trial.
Moderna halted the trial in July after it was informed that two babies in the vaccine group had developed severe RSV disease. The company didn’t publicly announce that the trial was discontinued until September.
The data presented Thursday at the Vaccines and Related Biological Products Advisory Committee meeting showed that 12.5% of vaccinated children developed severe RSV disease as compared to just 5% of children in the placebo group.
Among the children who developed symptomatic RSV disease, 26.3% in the vaccinated group progressed to severe disease, while only 8.3% of those in the placebo group did.
These results were concerning given the history of past attempts to develop an RSV vaccine for infants. In the 1960s, an experimental formalin–inactivated RSV vaccine for children led to two toddler deaths, and 80% of vaccine recipients required hospitalization for severe RSV.
The illnesses were attributed to vaccine-associated enhanced respiratory disease (VAERD) — a phenomenon that occurs when vaccination promotes immune responses that exacerbate the disease caused by subsequent infection with the pathogen the vaccine was meant to protect against.
In light of that history, and because the mechanisms that cause VAERD are still largely unknown, the FDA convened the advisory committee to discuss the implications of Moderna’s trial outcomes for other pediatric RSV vaccines.
The committee did not vote on Thursday or make any formal recommendations. Members watched presentations from consultants, the FDA, and pharmaceutical companies and discussed the risks and benefits of developing RSV vaccines for children.
They also commended Moderna for reporting its results and the existing clinical safeguards for recognizing early safety signals in pediatric RSV trials.
Vaccine makers developing 26 different RSV vaccines or monoclonal antibodies
The briefing document stated that the FDA was halting enrollment for all investigational trials for RSV vaccines for infants and toddlers under age 2 and children ages 2 through 5 who haven’t previously had RSV.
The FDA clarified at the outset of the meeting that the hold does not apply to vaccine candidates that use live attenuated vaccines, because there is no evidence that vaccines developed on this platform cause VAERD.
Advisers seemed to agree, except for Dr. Karen Kotloff who voiced concerns there was not enough information to assume that live attenuated vaccines don’t carry the same potential risk.
Dr. Pedro Piedra, who presented on clinical and non-clinical aspects of RSV vaccine safety shared a slide listing RSV vaccines and monoclonal antibodies currently in trials.
There are five pediatric vaccines other than Moderna’s — which Moderna’s Christine Shaw, Ph.D., definitively stated is no longer moving forward — in the pipeline. Four of them are for live-attenuated vaccines.
Vaccine makers are developing 26 different RSV vaccines or monoclonal antibodies for all age groups, all vying to enter a rapidly expanding market.
PR Newswire projected in 2023 the global RSV vaccine and antibody market would be worth $2.61 billion dollars in 2024 and rise to $13.59 billion by 2030.
Piedra — who began his presentation with the quick disclosure that he has grants for RSV prevention research from GSK, Icosavax and Merck and is a paid consultant in the field for Merck, Moderna, Pfizer and Sanofi — presented an optimistic picture of RSV vaccine development, citing protection offered by recently approved maternal vaccines and monoclonal antibodies.
Moderna’s results did raise some platform-specific concerns, Piedra conceded.
He listed the types of safety concerns that could be associated with different vaccine platforms — febrile seizures with adjuvanted or high-dose vaccines or when RSV vaccines are co-administered with other vaccines, autoimmunity that could be associated with new adjuvants, respiratory issues with intranasal vaccines, and systemic illnesses with vector-based or mRNA vaccines.
‘Unmet need’ as justification to push for more RSV vaxes for small children
Presenters repeatedly stated that there was an “unmet need” for pediatric RSV vaccines, especially for children between 8 months and 2 years old.
RSV usually causes mild cold-like symptoms, but in some cases can lead to hospitalization and death in infants and the elderly. By age 2, 97% of all babies have been infected with RSV, which confers partial immunity, making any subsequent episodes less severe.
The disease burden for infants can be serious. In the U.S., RSV infection is the leading cause of infant hospitalization among those younger than 6 months, although a very small percentage of children with the virus will die.
An FDA representative said the Centers for Disease Control and Prevention (CDC) estimates that 100-200 infants die per year from the disease. However, internist Dr. Meryl Nass told The Defender that even those low numbers may overestimate mortality.
Nass pointed to a CDC study analyzing RSV deaths in infants between 2005 and 2016 and found a total of 314 deaths in children under age 1, or 25 on average per year, Nass reported. Only 17 of those deaths per year listed RSV as the underlying cause of death.
The FDA also said that maternal vaccines and monoclonal antibodies had begun to reduce those numbers, but emphasized there is still an “unmet need” for a vaccine for children going into their second RSV season — even as it presented data showing hospitalizations in that season are lower.
Moderna said this “unmet need” drove them to develop their failed vaccine. A Sanofi representative, who gave an update on their live-attenuated RSV virus, said the company sought to meet that “unmet need” for children in their second RSV season.
Sanofi also sells nirsevimab — brand name Beyfortus — the monoclonal antibody shot the CDC recommends for all newborns to protect them in their first RSV season.
Sanofi and the National Institutes of Health (NIH) are collaborating on the live-attenuated virus vaccine platform. The NIH developed 16 different vaccine candidates that it trialed in children and currently has one SP-125 in Phase 3 clinical trials.
These vaccines have not shown VAERD after one season of surveillance, the Sanofi representative said. The safety trials showed no safety concerns and SP-125 is currently being tested for efficacy in toddlers 6-22 months of age, but it is not yet fully enrolled.
During the “public comments” section of the meeting, three other vaccine makers promoted their vaccines to the committee.
Goal is more RSV shots for kids to provide passive immunity followed by ‘active immunity’
FDA asked the committee members to discuss existing evidence on whether infants and toddlers could eventually get sequential administration of RSV monoclonal antibodies followed by RSV vaccines.
That would mean even more shots on the childhood immunization schedule. The monoclonal antibodies or maternal vaccination would provide babies with “passive immunity” — antibodies to fight the virus that weren’t created by their own immune systems.
Then, in this schema, a two- or three-shot course of an RSV vaccine could protect babies from RSV in the second season, giving them “active immunity.”
Most committee members said more data were necessary to evaluate the safety of such a plan, but they generally agreed that it was a good direction to move in.
Watch the meeting here.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
RFK Jr. and the Samoan Measles Outbreak
By David Marks | Brownstone Institute | December 15, 2024
When the nomination of Robert F. Kennedy, Jr. as Health and Human Services Secretary comes before the Senate, the specter of the Samoan measles outbreak of 2019 will dramatically be invoked to challenge him. Kennedy’s critics have repeatedly relied on this topic, citing stories that claim he was responsible for an epidemic in 2019 that caused at least 83 children to die due to vaccine hesitancy. In recent articles, reporters quote previous news coverage relying on unsubstantiated and minimal data to justify their analysis.
These stories repeat dubious assertions, fail to discuss any pathological analysis, and dismiss Kennedy’s considered support of healthcare in Samoa. He had assisted the Samoan government in developing a system for health officials to assess the efficacy and safety of medical interventions or drugs, including vaccines.
In November 2019, while the deaths of Samoan children were rapidly increasing, Kennedy wrote a comprehensive letter to the Samoan Prime Minister, presenting some possible causes of the unprecedented, virulent outbreak of measles. His concerns about the epidemic in Samoa highlight striking anomalies that were apparent to a few investigators at the time, although they remain unexplained.
The most convenient and generally accepted explanations of the outbreak claim the epidemic was the result of hesitancy, causing the population to be under-vaccinated. Measles vaccination rates were low due to the previous deaths of two infants given improperly formulated injections, which had nothing to do with Kennedy’s views.
Any considered analysis of the accessible facts soundly contradicts the conjecture that the high death count was related to low vaccination rates.
In most measles epidemics, mortality is on average one in one thousand, and dying children are often malnourished or immunocompromised. From October through December of 2019, over one in a hundred Samoan children with the disease died, ten times more than any previous outbreak in the world. No accounting for this overt statistical deviance has been published.
Despite the presumptions of those who attack Kennedy, there was never any investigation into any aspect of this baffling tragedy. Edwin Tamasese, a health advocate who questioned Samoan government policies during the outbreak, gave Kennedy some insight into what was happening.
Tamasese was concerned about the number of sick and dying Samoan children and began to assist families whose children were severely ill. He and his colleagues encountered conditions that contradicted the government’s narrative.
While the press condemned him as an anti-vaxxer, Tamasese’s interventions and observations are revelatory. In an interview after the outbreak subsided, he said, “We were very careful to take statistics when we were going in to try to identify trends. When we assessed our numbers, 98 percent of those who were getting ill had been vaccinated consistently six to seven days prior to illness. The excuse was that the vaccine did not have time to become effective. However, according to an immunologist on the team, the six to seven-day period was also the length of time it would take an under-attenuated vaccine to make the recipient sick.”
Doctors in hospitals also reported that the very ill and dying children did not have symptoms consistent with normal cases of measles. When the outbreak began, blood from the first thirty-nine cases had been sent to Australia; only seven samples were positive for measles.
The government stopped testing to confirm the cause of these deaths in early November 2019. Without scientific confirmation, illness and mortality were attributed to low immunization rates. Samoan health authorities continued to claim that the only remedy for the deadly epidemic was a drive to increase vaccination; however, the campaign appeared to increase the number of measles cases.
Neighboring Pacific island countries, Tonga and Fiji, which had concurrent outbreaks of the virus — and had a different source of the measles vaccine — did not suffer the same dramatic mortality rates. This should have raised concerns, yet there hasn’t been an inquiry into why the Samoan government switched vaccine sourcing from India to Belgium midway through the crisis.
A renewed effort to vaccinate with this alternate supply began in the first week of December 2019; it was hailed as the reason the outbreak subsided. Measles vaccines take at least 10 days before creating an immune response. There has been no explanation for the data confirming that the onset of cases dropped dramatically two weeks before this vaccination drive could have had any effect.
The government response was not driven by factual analysis; the effort focused on promoting the vaccine and silencing those questioning authority.
With Samoan officials and the press deriding his work and views, Tamasese was arrested and charged with incitement of a government order and treating children without a license. Although this was deemed appropriate justice by the international news media as they echoed the government’s praise of the vaccine, reporters again failed to present the questions raised by the outbreak.
The prosecution’s primary witness against Tamasese was a nurse whose child had measles. He had suggested that administering vitamins A and C could be helpful — and standard medical treatment for measles patients. She had taken his advice and admitted that her child recovered soon afterward.
Tamasese reported that when the nurse left the courtroom, the judge, in throwing out the case, said, “That witness may as well have represented the accused.” There was relative silence from the news media when all charges against him were dismissed.
While worldwide attention on Samoa ignored dramatic inconsistencies, Kennedy was one of the few people who asked detailed and important questions. His views were marginalized; it was easier and politically correct to blame the tragedy on low rates of vaccination.
The relatively few details known about the Samoan measles outbreak indicate that forces intent on presenting vaccines as an infallible, unquestionable remedy will not tolerate scrutiny or admit failures. This continuing devious tactic is applied internationally and is eagerly supported by most governments and the press.
Analysis of the Covid-19 pandemic has only recently vindicated those who were scorned for questioning the response. The parallels to the unfolding of the epidemic in Samoa are not obscure, and support Kennedy’s contention that vaccine development, manufacturing, and application need much more effective evaluation and monitoring to prevent complications and death.
When the US government assures the public that any vaccine or medication is safe and effective, this must come from an independent, thorough, and transparent process, rather than relying only on the words and actions of those with vested interests.
The current criticism of Kennedy is an endeavor to make him look dangerously ignorant and irresponsible to sway members of the Senate. Much to the chagrin of those who vilify him, his efforts to understand and assist in the Samoan measles outbreak exemplify his thoughtfulness and capabilities.
RFK, Jr. is at the forefront of healthcare oversight; his confirmation as HHS Secretary will ensure that Americans benefit from his experience and knowledge.
USS Harry S. Truman Leads American Naval Deployment to Middle East
Sputnik – 15.12.2024
The USS Harry S. Truman Carrier Strike Group arrived in the Middle East on December 14, entering the US Central Command’s (CENTCOM) area of responsibility. The deployment was announced by CENTCOM on the social media platform X.
The group includes the aircraft carrier USS Harry S. Truman, Carrier Air Wing 1 with nine aviation squadrons, the guided-missile cruiser USS Gettysburg (Ticonderoga class), and two guided-missile destroyers, USS Stout and USS Jason Dunham (Arleigh Burke class).
Earlier in November, US F-15E Strike Eagle fighter jets were deployed to the region from the United Kingdom, reinforcing the American military presence in the Middle East.
The deployment comes amid heightened regional tensions and US President-elect Donald Trump’s earlier remarks promising to avoid “starting wars” once he officially takes office.
How ex-Daesh and al-Qaeda leader al-Jolani became West’s blue-eyed boy in Syria
By Alireza Akbari | Press TV | December 15, 2024
Only a day after West-backed militant groups led by Hay’at Tahrir al-Sham (HTS) took control of Damascus, ending Bashar al-Assad’s long reign, HTS leader Abu Muhammad al-Jolani stood triumphantly on a hill overlooking the Syrian capital.
Wearing army fatigues, Ahmed al-Sharaa, popularly known as Jolani, looked on as plumes of smoke billowed into the sky—a grim spectacle of destruction wrought by Israeli bombings following the ouster of Assad’s democratically-elected government in Damascus.
The haunting scene evoked an eerie parallel to Emperor Nero, who infamously watched Rome burn while playing his lyre—portraying an image of power and apathy.
As the Israeli regime grabbed more Syrian land beyond the occupied Golan Heights and launched unprecedented airstrikes on Damascus, HTS militants gleefully roamed the streets, celebrating the “conquest,” and unleashed a brutal campaign of throat-slitting and terrorizing minorities.
The tumultuous events that eventually led to the overthrow of the Assad government began on November 27, when videos surfaced of militant groups in Aleppo making rapid advances.
These groups swiftly and dramatically escalated their advances, capturing strategic military bases in Idlib and Hama before marching toward the capital Damascus.
On December 8, they delivered a televised address from Damascus, declaring the end of Assad’s 24-year reign—a seismic shift in the region’s power dynamics with all eyes on Jolani as the leader.
Who is al-Jolani?
Abu Muhammad al-Jolani was born in Riyadh, Saudi Arabia, in 1982 to a Syrian family originally from the occupied Golan Heights of Syria, which has been under Israeli occupation for years.
His family returned to Syria in 1989, settling in Damascus’s affluent Mezzeh district. Jolani pursued media studies in Damascus before relocating to Iraq in 2003, just prior to the US invasion.
In Iraq, he joined the al-Qaeda terrorist group and became a key figure in the group.
He was captured by American forces in 2006 and spent five years imprisoned at Camp Bucca before being released in 2011. After that, he moved back to Syria and gained prominence as a militant leader.
Jolani’s journey through the ranks of Takfiri terrorist groups was spectacular as he became a close aide to top al-Qaeda leaders including Osama bin Laden and Ayman al-Zawahiri.
After his release from Camp Bucca in 2011, where he forged connections with future Daesh leaders, Jolani emerged as a key figure in the global Takfiri terrorist movement.
He initially served as a Daesh commander in Iraq’s Nineveh and Mosul provinces before being handpicked by Daesh chief Abu Bakr al-Baghdadi in 2012 to establish a Syrian affiliate at the outset of the West-backed militancy against the Assad government in the Arab country.
Jolani founded the Nusra Front as Daesh’s Syrian offshoot, leveraging the chaos to advance his agenda. However, a power struggle with al-Baghdadi over control of the group led to a split in 2013.
Jolani severed ties with Daesh and fortified his influence in Syria’s Idlib governorate, aligning the Nusra Front with al-Qaeda to retain the loyalty of hardline elements within his ranks.
While the split signaled a shift in allegiance, according to experts, it was less about ideology and more a personal rift. Jolani continued to espouse the Salafi ideology but sought to differentiate himself through a political veneer, setting him apart from figures like al-Zarqawi and al-Baghdadi.
Terror designation
The US State Department designated Jolani as a Specially Designated Global Terrorist in May 2013. By 2017, he was among the most wanted terrorists globally, with a $10 million bounty by the US government for information leading to his capture.
In an audio statement on September 28, 2014, Jolani declared his intent to fight the United States and its allies, urging his forces to reject Western assistance in their battle against Daesh.
Yet, just two years later, in July 2016, Jolani broke his pledge of allegiance to al-Qaeda leader al-Zawahiri, aiming to rebrand his militant organization and broaden its alliances.
This strategic pivot marked a shift in Jolani’s focus—from global ambitions to governance in Syria.
Following the establishment of the HTS militant group in 2017, the group took control of large swathes of Idlib, where they established a rudimentary governing structure.
HTS began collecting taxes and issuing identity cards to locals. However, these efforts were marred by authoritarian practices, including the suppression of dissent and the arrest of political opponents.
Despite Jolani’s public commitment to protecting minorities, his group adopted high-handed measures against religious and ethnic minorities, especially those who spoke about discrimination.
While HTS made rapid strides in consolidating power in the region bordering Turkey, its track record of human rights abuses in Idlib continued to be an area of concern.
The group has been known for systematically silencing dissent, targeting rivals, and using disproportionate force against those who opposed his authoritarian practices.
Concerns have also grown over the presence of foreign mercenaries in HTS, particularly those in its elite Red Brigades, which include members from Central Asia, Chechnya, and France.
Bigger political aspirations
Despite his Takfiri-militant roots, Jolani’s bigger political aspirations kept him in the news for years, as he continued to harbor ambitions of capturing Damascus from his hideouts in Idlib, financially and militarily backed by the United States, the Israeli regime and some regional countries.
Now, with HTS and its allies controlling significant territory in Syria, questions loom over how they will govern the country. Around 100,000 Syrians have already gathered on the border to enter Lebanon, according to reports, desperate to leave their home country.
Fears persist about the treatment of minorities, dissidents, and women under their rule, as many Syrians and the international community remain wary of Jolani’s true intentions.
Despite growing concerns over HTS rule, fueled by viral videos showing the group’s violent tactics, both the UK and the US are reportedly reconsidering its designation as a terrorist organization.
The British government is actively weighing the removal of HTS from its list of designated terrorist groups, particularly in light of the group’s pivotal role in the fall of the Assad government.
UK government minister Pat McFadden has suggested that such a move could be “relatively swift,” given the rapidly changing dynamics in Syria.
Similarly, US officials are debating the merits of removing the $10 million bounty on Jolani.
After years of lobbying for delisting, HTS appears to have gained traction with Western powers, particularly following its instrumental role in Assad’s ousting, a goal it shared with Western powers.
For years, the US and its Western allies had tried to dislodge the Assad government, using transnational mercenary forces as well as terrorist groups without much luck.
al-Jolani finally accomplished what his Western backers couldn’t for years despite massive efforts.
In his first detailed interview on Saturday, he emphasized engagement with Western nations and confirmed that the channels of communication with Western embassies, including talks with the British government to restore its diplomatic representation in Damascus, are underway.
He once again asserted that his regime has no intention of engaging in a conflict with the Israeli regime, despite Benjamin Netanyahu decimating the Arab country’s military muscle in a few days.
Global Majority nations are de-dollarizing trade with Panda Bonds and African banks
Inside China Business | December 13, 2024
Top African banks are key in the BRICS push to do more trade outside the US Dollar, and especially outside Western systems. By setting up branches inside China, African banks are able to borrow and lend in renminbi, the Chinese currency. This allows for cross-border trades to be settled in local currencies and RMB, instead of through USD-denominated letters of credit or debt markets. Panda Bonds are another tool, rapidly gaining in popularity and usage. Pandas are RMB bonds, sold to investors in Mainland China who want to diversify their fixed income investments to global borrowers. To borrowers, Panda Bonds offer lower interest costs than USD- or Euro-denominated debt, while also allowing for repatriation and currency swaps that are common in USD loans. Africa’s biggest banks, including those owned by African governments themselves, have set up in Mainland China and are increasingly integrated into China’s financial and industrial sectors. And large Chinese banks are heading the other way, investing heavily in Africa’s raw materials industries, and providing liquidity for Africa’s rising consumer class.
Resources and links:
Substack, for video transcript and direct links https://open.substack.com/pub/kdwalms…
South China Morning Post, African banks set up shop in China as Beijing pushes for yuan to eclipse US dollar https://www.scmp.com/news/china/diplo…
Statista, China’s African Trade Takeover https://www.statista.com/chart/26668/…
Africa’s Top 100 Banks 2024: Going global https://african.business/2024/09/fina…
S&P Global, Three Minutes In Panda Bonds: Why Issuance Is Surging https://www.spglobal.com/ratings/en/r…
Pfizer Failed to Disclose Deaths of Two Women in COVID Vaccine Clinical Trials
By Michael Nevradakis, Ph.D. | The Defender | December 13, 2024
Pfizer-BioNTech did not disclose the deaths of two vaccinated participants in its COVID-19 vaccine clinical trials, according to a team of Daily Clout researchers who analyzed documents related to the Pfizer clinical trials.
The deaths occurred before the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the vaccine in December 2020. However, it wasn’t until September 2023, nearly three years later, that the FDA publicly released documents revealing the deaths of a 63-year-old Kansas woman and a 58-year-old Georgia woman who participated in the trials.
The revelations prompted Dr. Jeyanthi Kunadhasan — an Australian anesthesiologist and perioperative physician and one of the researchers analyzing the Pfizer documents on behalf of Daily Clout — to write to Kansas Attorney General Kris Kobach, requesting his office investigate the death of the 63-year-old Kansas woman.
“If the additional two deaths had been disclosed at the time of the EUA, it would have shown that the BNT162b2 mRNA COVID vaccine intervention provided no reduction in deaths,” Kunadhasan wrote in her letter.
In June, Kobach sued Pfizer, alleging the company misled the public by marketing its COVID-19 vaccine as “safe and effective” while concealing known risks — including myocarditis and pericarditis, failed pregnancies and deaths — and critical data on limited effectiveness.
In 2022, a federal court ordered the FDA to release the approximately 1.2 million pages of documents pertaining to the clinical trials for the Pfizer-BioNTech COVID-19 vaccine, after rejecting the FDA’s request for 75 years to release the records.
The documents Kunadhasan analyzed revealed that Pfizer had the opportunity to disclose the deaths before the Dec. 10, 2020, meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) — but did not do so.
Pfizer also did not disclose the deaths — both classified in the documents as “sudden cardiac death” unrelated to the victims’ vaccination — in a December 2020 New England Journal of Medicine paper touting the “safety and efficacy” of the Pfizer-BioNTech vaccine.
Kunadhasan told The Defender :
“The death highlighted in Kansas is significant as it occurred well within the reporting period considered for the EUA, and as my letter shows was not disclosed. There was every opportunity to disclose this death at the VRBPAC meeting.
“This death even had an autopsy, which I show was probably available before the VRBPAC meeting, and again was not disclosed.”
According to The Sentinel, “The fact that both participants died of heart attacks becomes more important when other studies showed risks of myocarditis and pericarditis — particularly after a second shot and particularly in young men under 25, but among other patients as well.”
Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), told The Defender the actions of Pfizer and the FDA are “duplicitous at best.” He said:
“All death data for clinical trials needed not only to be made available to the FDA but also to the public. Otherwise, informed consent is completely missing, regardless of whether the product is EUA or [fully] approved.
“It is also particularly devious that Pfizer lied about a reduction in deaths in the vaccination arm when, with these data, the opposite was true.”
Naomi Wolf, Ph.D., CEO of Daily Clout and author of “The Pfizer Papers: Pfizer’s Crimes Against Humanity,” told The Defender the documents show that the “FDA covered up the unlawfully concealed deaths” of the trial participants and that these records “may well reveal a direct connection to the mRNA injection.”
“The details that Dr. Kunadhasan and her colleagues revealed about the death of this poor woman could theoretically allow Kobach to demand the autopsy reports and interview witnesses with information about her passing,” Wolf said.
Dr. Chris Flowers, a retired radiologist and member of the Daily Clout team that examined the Pfizer documents, told The Sentinel that the two undisclosed deaths should have been enough to halt the clinical trial.
“If you put it in context, yes, there’s a small number of deaths,” Flowers said. “Normally, the FDA calls a stop to those clinical trials until further investigation is done. And in many cases, [this] is sort of the death knell of that clinical trial.”
Noting that these deaths “would have at least made it more difficult” for the FDA to grant the Pfizer-BioNTech vaccine an EUA, Hooker said that “to release this information over two years later, after the obvious damage has been done, is criminal. Pfizer should be held accountable.”
Wolf said that while she’s “not an attorney, fraud, negligence and manslaughter come to mind.”
“This was one of the most important clinical trials in modern medical history,” Karl Jablonowski, Ph.D., senior research scientist at CHD, told The Defender. “The people in political power chose to ‘trust the science,’ and they were wrong to do so.”
Undisclosed deaths may have led to FDA granting EUA ‘on incorrect premises’
In her letter, Kunadhasan said she wants to draw attention to “an undisclosed participant death from Kansas that occurred in the BNT162b2-vaccinated arm of Pfizer’s clinical trial.”
Kunadhasan pointed out that Daily Clout published a report about the two undisclosed deaths in October.
According to the documents Kunadhasan cited, the death of the Kansas woman occurred “well before the data cutoff date of November 14, 2020” and nearly a month before the December 2020 VRBPAC meeting.
She said there was a 37-day delay in reporting the results of the Kansas woman’s autopsy, which revealed “sudden cardiac death,” Kunadhasan noted.
“Notably, the omission of the deaths and autopsy report from the vaccinated arm of the study at this critical juncture of EUA issuance raises substantial concerns about the overall safety reporting of Pfizer’s clinical trial,” Kunadhasan stated in the letter.
Kunadhasan also told the attorney general that Pfizer’s clinical trial protocol required that serious adverse events be reported: “immediately upon awareness, and under no circumstances to exceed 24 hours … Pfizer-BioNTech’s own clinical trial protocol indicated that it should have been disclosed.”
Referring to the New England Journal of Medicine paper, Kunadhasan noted that the paper disclosed only six deaths — two among vaccinated clinical trial participants and four among participants in the placebo group.
FDA documents released in September 2023, however, “included information showing that Pfizer-BioNTech was, in fact, informed of two additional deaths in the BNT162b2 arm of the trial well before the EUA data cutoff and that those deaths were not disclosed to the FDA,” Kunadhasan wrote.
The documents showed that the 63-year-old Kansas woman signed up for the Pfizer-BioNTech trial at the Alliance for Multispecialty Research LLC, in Newton, Kansas. She received the two doses of the vaccine on Aug. 18, 2020, and Sept. 8, 2020, and “had appropriate follow-up tests” done on Oct. 7, 2020.
“There is no documentation of any untoward clinical events during these visits,” Kunadhasan wrote. But on Oct. 19, 2020, 41 days after her second dose and less than two weeks after her follow-up visit, the woman died. A subsequent autopsy found the cause of death to be “sudden cardiac death,” not related to the vaccine.
“It is extremely important to know … Why this death (which occurred well within the reporting period) and the autopsy results were not disclosed publicly at the December 10th, 2020, VRBPAC meeting,” Kunadhasan said in her letter.
The letter also highlighted the death of the 58-year-old Georgia woman, who received her two doses of the Pfizer-BioNTech COVID-19 vaccine on Aug. 4, 2020, and Aug. 27, 2020. She died in her sleep on Nov. 7, 2020. Kunadhasan noted that her death was “not added to the data for 26 days.”
Kunadhasan told The Defender these discrepancies prompted her letter to Kobach.
“As a doctor, the non-disclosure of a death and autopsy of a clinical trial participant is a profound betrayal of medical ethics. I hope Kobach pays attention to this, and there can be accountability for this Kansan,” Kunadhasan said.
“Kansans should contact Kobach for action in regards to this letter and other AGs should follow suit with investigating Pfizer’s crimes in their states,” Wolf said.
Kobach’s office did not respond to a request from The Defender for comment as of press time.
Prominent cardiologist joins calls for suspension of mRNA COVID shots
Kunadhasan’s letter comes amid growing calls for a moratorium — or an outright ban — on the mRNA COVID-19 shots, and an independent investigation into their safety.
In an 11-page letter to U.K. regulators and health officials last week, cardiologist Dr. Aseem Malhotra joined these calls.
“There is overwhelming evidence that calls for the suspension of the COVID-19 mRNA vaccine (which, by technicality, is a genetic therapy) because of serious harms,” Malhotra wrote in the letter.
The letter was addressed to Charley Massey, CEO of the U.K.’s General Medical Council; Wes Streeting, the U.K.’s secretary of state for Health; Sir Christopher Whitty, the U.K.’s chief medical officer; and Lord Patrick Valance, the U.K.’s minister of state for Science Research and Innovation.
Malhotra wrote that these officials’ decision “to not support a pause and independent investigation of the safety of the vaccines is now untenable given accumulating evidence of harm and corrupt practices.”
The letter also referred to The Hope Accord — a petition Malhotra drafted earlier this year signed by over 64,000 people, including 1,900 medical doctors and over 2,000 scientists and academics.
The petition calls for the suspension of the mRNA COVID-19 vaccines, “comprehensive re-evaluation of the safety and efficacy of all COVID-19 vaccine products,” “immediate recognition and support for the vaccine-injured,” “restoration of ethical principles” and “addressing the root causes of our current predicament.”
Speaking on medical commentator John Campbell, Ph.D.’s YouTube show on Dec. 11, Malhotra said evidence supporting withdrawal of the vaccines is “overwhelming.”
Explaining why he wrote to U.K. officials, Malhotra told Campbell, “Sunlight is a very powerful disinfectant for malodorous health policy,” and said that there may be an explosion of people in the near future who are currently asymptomatic but who may develop vaccine-related conditions.
“We’ve got a lot of asymptomatic people in the population who I feel are at risk of heart attack, stroke and cancer. Until we get that addressed full on, more people are going to be harmed from a vaccine they took three years ago,” Malhotra said.
“My conscience will not allow me to stay quiet and just do this behind the scenes. As healthcare professionals, we need to address it because it’s not going away.”
“What we need to do is create almost a culture … where people aren’t afraid to admit that things have changed or they’ve got things wrong and they can change their mind,” Malhotra said.
Watch Campbell interview Malhotra here.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Transyouth Crusader, Dr. Johanna Olson-Kennedy, is Being Sued.
Possible landmark case against high profile practitioner of transgender medicine for minors
By John Leake | Courageous Discourse | December 14, 2024
The Economist recently published a succinct description of Dr. Johanna Olson-Kennedy’s eminent position in American transgender medicine for minors.
JOHANNA OLSON-KENNEDY is among the most celebrated youth gender-medicine clinicians in the world. She has been the Medical Director of the Center for Transyouth Health and Development at Children’s Hospital Los Angeles (CHLA), one of the first high-profile American youth gender clinics and presently the largest, since 2012. A frequent expert witness in court cases who is often quoted in the media, Dr Olson-Kennedy also leads a $10m initiative funded by the National Institutes of Health to study youth gender medicine—by far the largest such project in America. In addition, she is the president-elect of the United States Professional Association for Transgender Health.
Many readers of this description may struggle to grasp that Johanna Olson-Kennedy is a medical doctor who commits manifestly perverse atrocities against the most vulnerable, emotionally unstable members of the human race—that is, pubescent girls.
Had much of the U.S. medical profession not come unmoored from common sense, common decency, and the most elementary understanding of adolescence, Dr. Johanna Olson-Kennedy would already be in prison. I rejoiced at the news that she is being sued in what may prove to be a landmark case. As was just reported in ZeroHedge :
A 20-year-old woman has filed suit against California hospitals and doctors, saying they rushed to conclude she suffered from gender dysphoria and then “fast-tracked [her] onto the conveyor belt of irreversibly damaging” medical interventions that included puberty blockers, cross-sex hormones and a double-mastectomy at age 14.
According to the complaint filed in Los Angeles, Kaya Clementine Breen says she was sexually abused as a young child and that, around age 11 or 12, “began struggling with the thought of developing into a woman and began to believe that life would be easier if she were a boy.” When she shared those feelings with a school counselor, the counselor told Breen that she must be transgender, and then called her parents to push the same assumption as a fact.
Breen’s parents sought out “experts” at the Center for Transyouth Health and Development at Children’s Hospital in Los Angeles, including Dr. Johanna Olson-Kennedy, one of the world’s most vocal advocates for the gender-transitioning of children. “At her very first visit, after mere minutes, Dr. Olson-Kennedy diagnosed Clementine with gender dysphoria and recommended surgical implantation of puberty blockers,” according to the complaint, which also alleges that Olson-Kennedy neglected to perform a mental-health assessment or inquire about past trauma or abuse.
Echoing a grievance that commonly surfaces in the gender-transition realm, the complaint alleges Olson-Kennedy told Breen’s parents that their daughter would “commit suicide if she did not begin taking testosterone…At that time, Clementine had never had any thoughts of suicide, and she certainly had never expressed anything along those lines to Dr Olson-Kennedy.” According to The Economist, Olson-Kennedy’s own notes made no mention of suicidal ideation. Ironically, it was only after enduring transition procedures and “therapies” that Breen would later attempt suicide as her mental health declined and she contended with extreme depression and anger.
Stunning that such grotesque child abuse is allowed to happen in any nation that considers itself even remotely civilized.
Israel Gives Biden His Marching Orders
Syrian land will be annexed into “Greater” Israel
By Philip Giraldi • Unz Review • December 13, 2024
My former CIA colleague Larry Johnson has a real ability to clarify the significance of the constantly growing deep dark hole that Joe “Mumbles” Biden, he of failing mental capacity, has hurled the American people into. Larry wrote on December 12th that “There is still plenty of time before Donald Trump is inaugurated for Joe Biden’s team of cretins to start World War III. I think the biggest risk is that Israel may be emboldened to attack Iran and try to destroy sites, and may be encouraged to do so by the Biden lackeys. In short, American interference, at the behest of Netanyahu’s Israel, has left the Middle East in ruins, with over a million dead and open wars raging in Libya, Sudan, Somalia, Lebanon, Syria, and Palestine, and with Iran on the brink of a nuclear arsenal, being pushed against its own inclinations to this eventuality. The collapse of the Assad regime has prompted a punishing military response from Israel, which has launched airstrikes at military targets across Syria and deployed ground troops both into and beyond a demilitarized buffer zone for the first time in 50 years.”
Given the destruction and partitioning of Syria, it has become impossible to consider United States foreign policy without some acceptance that it is driven and, in a sense, directed by Israel and Israel’s formidable domestic lobby in the US. “The Lobby,” as it is commonly referred to, controls both Congress and the White House on key issues and manages the media narrative in such a fashion as to make Israel the permanent victim, never the aggressor. Even though Israel is now marching in triumph across what remains of Syria and has indicated that it will be sticking around as an occupier, the move is being described as “temporary” and “defensive” by White House spokesmen. The Lobby’s success rests on the corruption that lots of money can buy, obvious to nearly everyone in politics, but a forbidden topic, sometimes referred to as an antisemitic “trope,” i.e. “Jews and money.” Israel’s role in managing the Joe Bidens and Donald Trumps is largely exercised in the broader Middle East but it also includes passionately supporting Volodymyr Zelensky’s Ukraine, a process derived in part from Jewish mythologizing and obtaining revenge for the alleged “pogroms” carried out in imperial Russia. Subsequent Jewish dominance of the Soviet intelligence and security services, which saw the killing of millions of Christians in Russia, Ukraine and Eastern Europe, are carefully excluded from the narrative.
In the latest bit of “mowing the grass” by the Israeli military, the country’s new Defense Minister Israel Katz told the press that the Israel Air Force (IAF) had carried out more than 480 strikes across Syria during the two days after the initial invasion, deliberately destroying most of Syria’s strategic weapon stockpiles. Meanwhile, the Israeli navy totally destroyed the Syrian fleet based at Latakia overnight. Katz hailed the operation as “a great success.” Israeli Prime Minister Benjamin Netanyahu, on the day before, had called the rapid defeat of Bashar al-Assad’s regime as “a new and dramatic chapter… The collapse of the Syrian regime is a direct result of the severe blows with which we have struck Hamas, Hezbollah and Iran… we are changing the face of the Middle East.”
When informed of the initial invasion of al-Assad’s Syria by Israeli, Turkish, insurgent and US forces, Donald Trump said that the conflict was none of our business and it would be best to keep out of it. Hopefully that will be the policy after January 20th’s inauguration, but one recalls that Trump’s record of pandering to Israel is almost as bad as Biden’s, and he was the one who decided (admittedly under pressure from the Pentagon) to continue in 2017 the military occupation of a third of Syria that included its oil resources and its best agricultural land. Add in the crippling US and European sanctions on Damascus and one might argue that since that time Syrians have been poor and starving, causing refugee flows and hostility towards the al-Assad government that contributed to the success of the recent uprising.
To be sure, many Syrians are celebrating the fall of an admittedly repressive, authoritarian, and corrupt Bashar al-Assad government. But other Syrians, particularly from hitherto protected minority groups like Christians, Alawites and Shiites, are now living in fear of or fleeing from the violent sectarian insurgents that have taken the place of President al-Assad. Christian Churches have already been looted and desecrated and warned not to hold Christmas services, not to sponsor Christmas parades, and not to display the image of St. Nicholas.
To be sure, fearing what is to come is legitimate as the “rebel” leader of the al-Qaeda derived Hayat Tahrir al-Sham (HTS) Terror group, Abu Mohammad al-Jolani, who now goes by his given name Ahmed al-Shara, is a founder of al-Qaeda in Syria, al-Nusra, and a former deputy to ISIS leader Abu Bakr al-Baghdadi. The US State Department has listed him as a terrorist as well as HTS as a terrorist group, and has placed a $10 million bounty on al-Jolani’s head, which presumably will soon be removed by Joe Biden. There is plenty of blood on al-Jolani’s hands and little in the way of evidence that he will not opt to slaughter those who he sees as his enemies, much of the killing being guided by the extreme religious groups that make up his followers. Indeed, there are already reports of group killings, including numerous soldiers in the Syrian Arab Army who surrendered rather that fight the insurgents.
Al-Jolani now claims that his extremism was just a “phase” and he has several times confirmed that he wants good relations with Israel, clearly a condition imposed by the US to allow him to remain in power. He has even suggested that Israeli air support enabled his warriors to move quickly from their bases in the north to Damascus. But al-Jolani has never actually apologized for or disowned the atrocities committed on his watch in 2011-3 when he was actively killing fellow Syrians. This includes August 2013 massacres in some of the Alawite areas of Latakia, which included “the systematic killing of entire families,” an international investigation later determined. One observer also reported that the insurgents were devoted to “sectarian mass murder” This is the legacy of the new “inclusive” government in Syria. According to one other ominous report, it appears that Sharia law has already been announced by the newly installed justice minister, Shadi Alwaisi.
So, what is in it for the United States? Nothing but a curt thank you from Prime Minister Benjamin Netanyahu, who clearly connived with Joe Biden’s Special Envoy Amos Hochstein, an Israeli by birth, to set the ball rolling towards Syria through adroit use of an attack on southern Lebanon to disarm Hezbollah followed by a phony ceasefire in Lebanon that gave Netanyahu a free hand and empowered Israel to invade and overthrow its neighbor Syria, parts of which will undoubtedly be annexed to help create Eretz or “Greater” Israel. It was and is all part of a plan by the US and Israel to reshape the Middle East to benefit the Jewish state and you can bet that Iran is the next target. And a delusional Joe Biden took credit for it all in his usual haphazard way, claiming after the regime change that Assad’s “main allies” — Iran, Hezbollah, and Russia — “are far weaker today than they were when I took office.” Their inability to save Assad was “a direct result of the blows that Ukraine, Israel have delivered upon their own self-defense, with unflagging support of the United States.”
Sure Joe, what bullshit. At the end of the day, to bring down Syria the US spent billions of dollars arming an insurgency that they knew was dominated by al-Qaeda in a government replacement scheme that benefited only Israel and Turkey and which targeted a country that in no way threatened the United States. It sure makes sense to me and I hope you will be comforted by it when you are hauled off to prison after you leave office and are prosecuted for exceeding your constitutional authority by involving the United States in two unnecessary wars. Some might call it treason!
Philip M. Giraldi, Ph.D., is Executive Director of the Council for the National Interest, a 501(c)3 tax deductible educational foundation (Federal ID Number #52-1739023) that seeks a more interests-based U.S. foreign policy in the Middle East. Website is councilforthenationalinterest.org, address is P.O. Box 2157, Purcellville VA 20134 and its email is inform@cnionline.org.
Trump is a nightmare for the EU in more ways than one
With its submissiveness to the US and contempt for its president-elect, the bloc’s set itself up for a perfect storm of punishment
By Tarik Cyril Amar | RT | December 14, 2024
For a man his age, incoming US president Donald Trump has a knack for cultivating a bad-boy image. Refreshingly direct to the point of rude honesty, or dishonesty, as the case may be, he has no time for polite circumlocution. His threats are harsh, his demands unvarnished, including toward Washington’s so-called allies in Europe, which really are, at best, clients, and, more realistically, just vassals. In that spirit of candid, no-frills domination, Trump already has a long record of threatening NATO, which he sees – plausibly – as a scam in which European members fleece the US to free-ride on its insane (but that’s a different story…) military spending.
Or, in the genteel English still cultivated at The Economist, “through NATO, America is the guarantor of the continent’s security.” Yeah, right, by firing missiles at Russia… The problem with Trump is that he is uncouth enough to know the real relationship is much more like Don Corleone “protecting” your funeral parlor. And he behaves accordingly: Even during his first term in the White House between 2017 and 2021, he started scaring other NATO members into higher military spending, while never allowing them to feel safe about his commitment. Art of the tough deal: Keep ‘em guessing, keep ‘em on their toes. And it worked, too: the European spongers began to pay more. So, there will be more of that, rest assured. If, that is, there will be a NATO to speak of.
Even less noticed is the fact that the new old US president – and thus capo dei capi of the West – is not much kindlier disposed toward the EU. And yet there it is: Trump’s frank, open, and long-standing dislike for that strange bureaucratic behemoth that is about as democratic as the former Soviet Union, less efficient than the Habsburg Empire, and so full of its global “norm-setting” mission that even American “indispensability” looks oddly old-fashioned by comparison.
As early as the beginning of 2017, when the great American bruiser gate-crashed the White House for the first time, The Economist warned its European readers to “be afraid” of Trump, a man harboring “indifference” and “contempt” for the EU. Really? How unheard of! The raunchy-tycoon-turned-peremptory-president, the British establishment Pravda of neoliberalism and Russophobia explained, would seek to shatter the EU by playing “bilateralism.” That, of course, is Euro-babble for respecting individual countries’ governments by taking their sovereignty more seriously than power-grabbing delusions of grandeur in Brussels. And – oh, horror! – he might even try to talk Russia. (Spoiler: back then he did not – big mistake.)
That, however, was 2017. Now, things have moved on. Even before Trump won his second presidential election by crushing his Democratic opponents, The Economist admitted that “’Trump-proving’ Europe” is a notion doomed to fail, which means EU leaders may well become “geopolitical roadkill.” How so, you may wonder?
Well, first of all there is Russia. Regarding Moscow, Trump seems ready to talk, and in a substantial manner we have not seen since the end of the Cold War: He has publicly signaled that he does not believe in trying to coerce Moscow by further escalation; his freshly appointed advisers Mike Waltz and Keith Kellogg, though known for ambiguous signals in the past, will fall into line, as they should as public servants. And if not, they’ll be fired, Trump-style, fast and without remorse.
To say the least, Trump no longer feels as restrained by Washington’s deep-state, deep-freeze Cold War re-enactors as during his first term. Sure, it’s the US: there is always the possibility someone might try to murder him, again. But if he stays among the living, which is likely, then it’s payback time: Talking to Russia now is one delicious way in which he will dish out well-deserved retribution for both the media-lawfare circus of Russia Rage (aka ‘Russiagate’) in which his opponents weaponized slander and disinformation against him. And, more importantly, Russia has been winning the war in Ukraine, not only against Kiev but also, in effect, against the West. In sum, Trump has less reason to be afraid of his own backstabbers at home, and Washington has more reason to be much more careful about Russia.
Moscow, meanwhile, has made it clear repeatedly that any new agreements would have to be mutually beneficial. The time of Gorbachevian naivete will never return. Yet, at the same time, Russia does seem open to – serious – talks: The Russian leadership does not merely carefully watch Trump, as you would expect. It also sends back calibrated pings that signal cautious appreciation of his overtures, as recently over his criticism of firing Western missiles at Russia.
Hence, nightmare number one for the EU: Trump is serious about ending US support for the failed project of inflicting a geopolitical demotion on Russia via a proxy war in Ukraine. That will leave not only the regime of Ukraine’s past-use-by-date leader Vladimir Zelensky high and dry but remaining fanatics in the EU as well. In the best-case scenario, the US will leave the European vassals with the cost of the postwar, whatever shape that may take. Trump has already said as much. In the worst-case scenario, EU elites could try going it alone. That is, worst-case for them, in every (un)imaginable way: economically, politically, and yes, militarily, too.
And behind Trump’s willingness to make good on his election promise to end the American cluster-fiasco in and over Ukraine, lurks the possibility of a much larger turn toward – wait for it! – diplomacy in the US-Russia relationship. Perhaps it is early days to mention that other long-forgotten D-word – and it would also take two to tango, of course – but a phase of détente cannot be excluded. If it were to take place, America’s European vassals would come to regret burning their bridges with Moscow to please Washington.
Then, nightmare number two, there is the economy. The US-EU relationship is the single largest trade connection in the world, worth about $11 trillion per year. That, you may think, constitutes a lot of common interest and thus reasons for treating each other if not gently then, at least, cautiously. Nope, that’s not how this works, because the relationship is lopsided, and Trump is furious about it. For him, the EU’s trade surplus with the US is yet another way in which shifty Europeans have been milking America. His weapon of choice to retaliate and rectify the situation are, of course, tariffs, the higher the better. Even before his re-election, Goldman Sachs warned that his rule could cost the EU as a whole a full percent of GDP. And yes, that’s a lot, especially for a continent already largely economically depressed, demographically declining, and with badly squeezed public finances.
What can EU leaders, those sadly submissive vassals about to be abused even worse than usual by their hegemon, do now? Frankly, not much. It’s already too late: They have made themselves dependent as never before on whoever happens to win the strange event Americans call “elections” and gets to mess with the world from the White House. And that is not at all Trump’s fault, by the way. (No, and not “the Russians!” either…).
Take, for instance, the EU’s wannabe despot Ursula von der Leyen. Building her own power grab – like Stalin, as it happens – on a mix of executive apparat overreach, crony networking, and ideological bigotry, she has made one serious mistake that may cost her dearly: She has cozied up so shamelessly to the outgoing Biden administration that, serious rumor has it, Trump cannot stand her. So, alternatives are in demand: Maybe he likes Italy’s Giorgia Meloni better? Or originally the Netherlands, now NATO’s Mark Rutte, who is constantly praised for his alleged “Trump-handling” skills?
But here is the problem with that, frankly, silly approach: Trump is not an idiot. Attempts to “handle” him are insultingly obvious and, if he tolerates them temporarily, then it’s only to handle his would-be handlers back. And then the irony is, of course, that the only EU leaders Trump respects, such as Viktor Orban of Hungary, are outcasts among their own: Good luck recruiting them now to make up for how much he disrespects all the others. Maybe they’ll even help, a little, Ursula, Olaf, and Emmanuel. But it’ll cost you, because they will – rightly – set their own conditions and gain great leverage.
What about Danegeld perhaps? Danegeld, you must know, was what the hapless inhabitants of the British Isles paid the seaborne Viking marauders in the Dark Ages. The system was simple: pay up or be plundered and slaughtered. You think that sounds a little primitive for today’s sophisticated Europeans? Never underestimate how low they will stoop. Ursula von der Leyen has already suggested that one way to mollify Trump might be to just buy even more perversely expensive LNG from the US. Christine Lagarde, head of the European Central Bank, has gone even further, pleading for a whole ‘Buy American’ program, including – surprise, surprise! – arms to assuage Trump’s ire.
Desperate? You bet. Humiliating? Obviously. Yet what’s worse, it’s not going to work. Here’s why: Even if Trump condescends to accepting such tributes from his European subjects, he will never lose sight of the one thing that really interests him (apart from his own money, power, and fame): American advantage. Whatever the Europeans will offer and however low they will kowtow, in the end, any deal will be good only for one side, the US. That’s ironic, because Russia, for one, and possibly China as well can expect the minimum of respect that makes mutual benefit at least possible. That’s because they have stood up to American bullying. For the Europeans, though, it’s a Catch 22 now. One way or the other, they will pay even more dearly than before for their historic failure after the Cold War: When they should obviously have emancipated themselves from the US, they sold out worse than ever. And without need. To paraphrase a past master of politics: It’s worse than a crime, it’s self-abuse.
Tarik Cyril Amar is a historian from Germany working at Koç University, Istanbul, on Russia, Ukraine, and Eastern Europe, the history of World War II, the cultural Cold War, and the politics of memory.
Clintons Open to Possible Preemptive Pardon as Deep State May Abandon Them
By Ekaterina Blinova – Sputnik – 13.12.2024
Former President Bill Clinton has indicated he is open to discussing a “pre-emptive pardon” for his wife, Hillary Clinton, with outgoing head of state Joe Biden, while maintaining that she has done nothing wrong.
This development was anticipated, according to Wall Street analyst Charles Ortel, who tells Sputnik that Bill Clinton is also likely to seek a pardon for himself and his daughter.
Ortel adds that the proposed pardon could cover a period starting much earlier than Hillary’s 2016 email scandal, which Bill Clinton mentioned on “The View” talk show.
The alleged fraud and pay-to-play activities involving the Clinton Foundation were significant issues, according to Ortel, who has been investigating the charity for many years.
“As in the case of the first Biden family pardon, my view is that a federal pardon for the Clinton family will have to go back, perhaps, to 1992 and continue so long as ‘The Clinton Foundation’ and its affiliates may operate,” Ortel suggests.
Earlier, Biden provided his son with an unusual blanket pardon covering all possible crimes between 2014 and 2024.
The Clintons “have been insiders in a rigged political system at the federal level” since Bill’s first presidential campaign in 1992, Ortel claims.
However, even a federal pre-emptive pardon from Biden “is likely to leave Bill, Hillary, and Chelsea Clinton vulnerable to state and foreign prosecutions, along with others,” the analyst believes.
Kash Patel Has Hillary Clinton on His “Government Gangsters” List
Bill Clinton’s readiness to discuss a pre-emptive pardon with President Joe Biden is likely influenced by FBI Director Christopher Wray’s decision to step down and Donald Trump’s nomination of Kash Patel, according to Ortel.
Ortel suggests that Wray is part of the same cabal as former FBI Director James Comey, who allowed Hillary Clinton to escape consequences for her 2016 email scandal.
In contrast, Patel has never been part of the D.C. “swamp” and played a key role in debunking the Trump-Russia collusion allegations, which, based on then-CIA Director John Brennan’s declassified memo, may have been fabricated by Hillary Clinton to divert attention from her email scandal.
According to Ortel, the Department of Justice (DoJ), FBI, and IRS have long covered up the Clintons’ apparent felonies, despite many being evident.
“When the FBI finally spoke with me in December 2018, they focused on my connections with Peter Smith, Jerry Corsi, and Roger Stone, claiming they lacked the scope to investigate why so many in the Obama and Bush administrations might be interested in covering up Clinton Foundation crimes,” Ortel says.
If Patel takes charge of the FBI, he is expected to overhaul the bureau and could investigate the Clintons earnestly, according to Ortel. Reports indicate that Hillary Clinton is on Patel’s “government gangsters” list.
Clintons Have Outlived Their Usefulness to Deep State
The globalist elites and much-discussed US “deep state” may no longer shield the Clintons, as they have outlived their usefulness, Ortel says.
“Bill Clinton, Hillary Clinton, Barack Obama, and Joe Biden have outlived their usefulness to rich globalists,” Ortel states.
The election defeat of Vice President Kamala Harris, along with the inability of the Clintons, Obamas, and Bidens to produce a more vibrant and popular presidential candidate, apparently exposed their political bankruptcy.
As a result, BlackRock CEO Larry Fink, who has long been considered an ally of the Democrats, dismissed the party’s gloom-and-doom warnings and openly signaled in October that a Donald Trump victory would be acceptable for Wall Street.
“Should the Trump administration prioritize prosecuting charity crimes, starting with wealthy donors like Bill Gates and George Soros and wealthy ‘educational public charities,’ whistleblowers and the incoming administration could make America proud by [taking down] the Clinton family and many other charity grifters who, even today, seem arrogantly unrepentant and unbowed,” Ortel concludes.
Featured Video
Billionaires and Officials Are Just Blatantly Ignoring the Will of the People
or go to
Aletho News Archives – Video-Images
Villains of Judea
Samuel Zemurray
The ruthless businessman who financed coups in Central America and shaped Israeli statehood
José Niño Unfiltered | May 7, 2026
Leftist commentators consistently push a shallow and economically reductive narrative that frames American foreign policy as the sole domain of greedy White capitalists while choosing to ignore the obvious Jewish power structure directing these events. When the veneer of this supposed corporate imperialism is stripped away, it becomes clear that the United States has often served as a vehicle for the specific goals of organized Jewry. The life of Samuel Zemurray stands as prime evidence of this hidden mechanism.
Few figures in American business history wielded power as ruthlessly or as secretly as Zemurray. Born Schmiel Zmurri on January 18, 1877, to a poor Jewish family in Imperial Russia, this teenage immigrant would rise from peddling rotting bananas off railroad cars in Alabama to become the controlling force behind the United Fruit Company, the most powerful agricultural corporation on earth. Along the way he overthrew governments, bribed presidents, hired mercenaries, and played a pivotal behind-the-scenes role in the creation of the State of Israel. … continue
Blog Roll
Aletho News- Hamas leaders say targeting families will fail to extract concessions
- Harrowing testimonies expose Israeli torture of Gaza hospital director
- UAE provides $100m for US-backed Gaza police force vetted by Shin Bet
- Britain quietly approves $11.85m arms licence to Israel despite Gaza ban
- Britain’s population replacement has passed the point of no return
- US-Iran ‘Calibrated Escalation’ Risks Sliding Into All-Out War – Expert
- Iran – End of the Drought & the Destruction of US Radar Installations in the Middle East
- Prediction: NATO’s Collapse & Nuclear War
- ‘Operation Fauxios’: Axios, Israeli spy, and $2 billion oil scam to prop up Trump
- Iran blasts US ceasefire violations, says Washington trapped in ‘self-created quagmire’
- If Americans Knew
- A Conservative’s View: Trump’s War on Iran Is Destroying America
- Israel’s war on the West Bank comes for Palestinian greenhouses
- New $270 million Israeli-only roads project in the West Bank is Netanyahu’s latest bid to impose de facto annexation
- Gaza investigation: A family’s fight to find their missing relatives
- MSF: Israel’s deliberate restriction of food and aid led to alarming malnutrition levels in Gaza
- Israel earmarks $270M for Israeli-only roads (that’s apartheid) – Daily Update
- Two Supreme Court Justices were secret agents who helped Israel cover up its attack on the USS Liberty
- Bari Weiss ‘Meddles’ With ‘CBS Sunday Morning’ Story on Palestine
- Zionists Are Gunning for Your Freedom of Speech
- The horrors in Gaza continue: Here are the facts
- No Tricks Zone
- New Study: Declining Trends In 1980-2023 Tropical Cyclone Frequency, Accumulated Energy
- 46 IPCC Scientists Break Rank, Publicly Challenge Long-Standing Dogmatic Climate Claims
- Another Study Links Warming To Cloud Forcing, Shortwave Radiation, Natural Atmospheric Circulation
- Wind Energy Is Toxic, Hazardous To Human Health, Scientific Review Shows
- Oversupply Of Volatile Solar Energy Leads To Record NEGATIVE Prices!
- New Study: Extreme Heat Records, Heatwaves, Extreme Cold Records Declining Across US Since 1899
- It’s The Cold, Stupid! Cold 20 Times More Lethal Than Heat, Multiple Studies Show
- European Institute For Climate And Energy: “Climate Debate is Seldom About Science”
- New Study: The Climate May Be 5 Times More Sensitive To Solar Forcing Than Commonly Assumed
- EV Industry Reached $70 Billion In Losses In 2024 Due To Delusional Green Ideologies
Aletho News 